UBS Raises Price Target on Albemarle (ALB) to $85 Following 3Q Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Wall St slides as oil hovers near $100 on rising Middle East tensions
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Oil nears $100 as fresh Middle East strikes raise supply risks
- How big a risk are rates to the AI boom?
- 3 reasons why S&P 500 may drop up to 10% in the near term: RBC
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Albemarle (ALB) Announces Election of New Board Chairman
November 8, 2016 6:27 AM ESTThe board of directors of Albemarle Corporation (NYSE: ALB) announced its decision to elect president and chief executive officer, Luke Kissam, as chairman, effective November 7, 2016. He assumes this title in... More
Albemarle (ALB) Tops Q3 EPS by 10c, Updates FY Guidance
November 7, 2016 5:36 PM ESTAlbemarle (NYSE: ALB) reported Q3 EPS of $0.91, $0.10 better than the analyst estimate of $0.81. Revenue for the quarter came in at $654 million versus the consensus estimate of $645.81 million.
GUIDANCE:
Albemarle sees Q4 2016 EPS of $3.45-$3.55, versus the consensus of $3.48. Albemarle sees Q4... More
Trading Radar for 11/7: MGM Resorts (MGM), LendingClub (LC), Dean Foods (DF), Ferrari (RACE), Sysco (SYY) Report
November 4, 2016 3:49 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
ARIAD Pharma (Nasdaq: ARIA) - consensus loss $0.19
Altisource Residential (Nasdaq: RESI) - consensus loss $0.48
Amicus Therapeutics (Nasdaq: FOLD) - consensus loss $0.34
ArQule (Nasdaq: ARQL) - consensus loss $0.09
Aralez Pharma (Nasdaq: ARLZ) - consensus loss $0.37
Ardelyx (Nasdaq: ARDX) -... More
